The Oncology Institute, Inc. (STLN) News
Follow The Oncology Institute, Inc. (STLN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
STLN: Rapidly scaling oncology VBC platform with strong growth, profitability, and clinical outcomes
A national oncology VBC platform is achieving rapid revenue growth, expanding its patient reach, and maintaining strong profitability through a balanced business model, proprietary technology, and industry-leading clinic
EQUITY | Sep 08, 2026, 07:19 PM UTC
L
Brad Hively steps down from Star board and vice chairman role
Star notified that Brad Hively will not stand for re-election to the board and has stepped down as vice chairman and committee member, effective immediately.
REGULATION | Sep 02, 2026, 10:13 AM UTC
L
Starling Oncology Form 4 filed by 10% owner Chernett Jorey P
Starling Oncology, Inc. discloses a Form 4P filing showing 10% owner Chernett Jorey P sold 12,000 shares at $6.54 for $78,480.
REGULATION | Aug 17, 2026, 02:14 PM UTC
H
Premarket Gainers: MB +160.79%, NAMI +134.09%
MB and NAMI lead premarket gainers
EQUITY | Aug 07, 2026, 09:22 AM UTC